+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Gastroduodenal mucosal injury in patients on antiplatelet therapy

Gastroduodenal mucosal injury in patients on antiplatelet therapy

Thrombosis Research 120(4): 465-469

In vitro bioassays are widely used to detect and quantify endocrine disrupting chemicals (EDCs) in the influents and effluents of municipal wastewater treatment plants (WWTP). These assays have sometimes led to false positive or negative results, partly due to the low EDC concentrations in the samples.

(PDF emailed within 0-6 h: $19.90)

Accession: 015916440

Download citation: RISBibTeXText

PMID: 17257659

DOI: 10.1016/j.thromres.2006.12.010

Related references

Prevalence of gastroduodenal mucosal injury in asymptomatic patients taking antiplatelet agents in Japan. International Journal of Clinical Pharmacology and Therapeutics 47(12): 722-725, 2010

Effects of gastric medicines on gastroduodenal injury in patients with stable angina during antiplatelet therapy. Journal of Cardiology 54(1): 71-75, 2011

Investigation of Gastroduodenal Mucosal Injury in Japanese Asymptomatic Antiplatelet Drug Users. Medicine 94(26): E1047-E1047, 2015

Are Japanese patients more prone to gastro-duodenal mucosal injury and bleeding with the use of antiplatelet agents?. Thrombosis Research 120(4): 463-464, 2007

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. Bmj 308(6921): 81-106, 1994

Comparison of salsalate and aspirin on mucosal injury and gastroduodenal mucosal prostaglandins. Gastroenterology 99(6): 1616-1621, 1990

Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease. Internal Medicine 49(23): 2537-2545, 2011

High prevalence of gastroduodenal mucosal injury in patients taking selective serotonin reuptake inhibitors. Digestive Endoscopy 22(1): 77-77, 2010

Gastroduodenal mucosal injury in patients taking low-dose aspirin and the role of gastric mucoprotective drugs: possible effect of rebamipide. Journal of Clinical Biochemistry and Nutrition 47(1): 27-31, 2010

Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs. Gut 51(3): 336-343, September, 2002

Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients. Cardiology 122(3): 148-157, 2012

Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction. Journal of Gastroenterology and Hepatology 25 Suppl 1(): S119-S121, 2010

Effect of aspirin cessation before endoscopy in Japanese patients with low-dose-aspirin-associated gastroduodenal mucosal injury. United European Gastroenterology Journal 1(4): 259-264, 2014

Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. Bmj 308(6923): 235-246, 1994